Comprehensive service for discovering and identifying new cancer biomarkers in human serum and plasma samples to advance precision medicine and diagnostics.
Manufactured by
Berlin, Germany
Since 1999, we have been innovating in the diagnostics space to make a healthier world. From being a Native Antigen manufacturer, we have substantially enhanced our portfolio over the years to become a premium provider of IVD raw materials and pre-clinical drug discovery services. Our relentless passion to make a healthier world drives us to continually focus on the emerging unmet needs in the diagnostics space and become the preferred partner to our customers worldwide.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
BioChain (Beijing) Science & Technology. Inc.
China · 2 relevant products
PreceDo Pharmaceuticals Co.Ltd.
China · 2 relevant products
Anhui Yisheng Medical Technology Co., Ltd
China · 1 relevant product
Jiangsu Avatarget Biotechnology Limited Liability Company
China · 1 relevant product
NOROVA
China · 2 relevant products
Shanghai Biotecan pharmaceuticals Co.,Ltd
China · 2 relevant products
i Med Laboratories Co., Ltd.
Thailand · 1 relevant product
PHC Corporation
Japan · 1 relevant product
Aliko Scientific SA
France · 3 relevant products
Burning Rock Dx Co. Ltd.
China · 2 relevant products
46 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →5 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 78 closest product alternatives
BioChain (Beijing) Science & Technology. Inc. · China
A targeted blood-based early detection service for specific cancer types utilizing gene methylation biomarkers. This clinical testing service is performed by BioChain's certified medical laboratory.
BioChain (Beijing) Science & Technology. Inc. · China
A comprehensive blood-based screening service designed to detect multiple cancer types simultaneously through gene methylation analysis. This service utilizes advanced NGS technology and is available as a clinical testing service.
PreceDo Pharmaceuticals Co.Ltd. · China
A high-throughput drug sensitivity testing platform utilizing renewable primary cancer cells to predict treatment response. This service enables personalized treatment selection through comprehensive chemotherapy and targeted drug profiling.
Anhui Yisheng Medical Technology Co., Ltd · China
Detection service offering laboratory analysis and diagnostic testing for clinical specimens. Supports medical institutions and healthcare providers with accurate pathology and biomarker identification. Enables timely disease diagnosis and treatment monitoring through specialized analytical protocols.
Jiangsu Avatarget Biotechnology Limited Liability Company · China
Clinical service for personalized cancer drug response evaluation using patient-derived tumor organoids and organ chips. Supports precision medicine treatment selection and optimization.
PreceDo Pharmaceuticals Co.Ltd. · China
High-throughput DNA sequencing service for clinical sample analysis and genomic profiling. This service enables identification of disease-associated genetic variants for precision medicine applications.
NOROVA · China
Precision diagnostic service utilizing liquid biopsy technology for early detection and monitoring of malignant tumors. Analyzes circulating biomarkers from patient blood samples. Enables non-invasive assessment of tumor characteristics and treatment response.
NOROVA · China
A diagnostic service utilizing independently developed CTC (circulating tumor cells) and ctDNA (circulating tumor DNA) detection platforms with high sensitivity and specificity. Compared to traditional detection methods, it can identify more disease information to achieve individualized precision therapy for tumor patients. Liquid biopsy is minimally invasive and painless, providing comprehensive tumor-related information from a single blood sample, offering strong support for malignant tumor diagnosis and treatment as a complement to traditional tissue biopsy.
Shanghai Biotecan pharmaceuticals Co.,Ltd · China
High-throughput sequencing detection service for tumor-derived circulating free DNA genetic mutations, enabling precise tumor profiling and monitoring. The service has passed national inter-laboratory quality assessments with full marks.
i Med Laboratories Co., Ltd. · Thailand
Diagnostic test for detection of cancer biomarkers in blood and body secretions. Identifies biomolecules produced and released by cancer cells for screening and monitoring purposes.
PHC Corporation · Japan
Laboratory testing services specializing in cancer detection and identification through tissue analysis and biomarker assessment. These services support early detection and treatment planning for cancer patients.
Aliko Scientific SA · France
Comprehensive diagnostic solutions for cancer detection and treatment monitoring utilizing FISH and circulating tumor cell (CTC) detection technology. These solutions enable personalized medicine approaches and targeted therapy delivery.
66 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products